Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest

NCT05558228 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2023-09-28

No results posted yet for this study

Summary

The FloPatch FP120 device is indicated for use for the noninvasive assessment of blood flow in the carotid artery. The FloPatch FP120 device uses ultrasound and the Doppler effect to non-invasively assess the flow of flood. In this study, the FloPatch FP120 will be applied to the neck at the location of the carotid artery on cardiac arrest patients in the emergency department. FloPatch FP120 data will be compared with arterial line blood pressure to assess for accuracy of pulse checks among cardiac arrest patients in the emergency department.

Conditions

  • Cardiac Arrest

Interventions

DEVICE

FloPatch FP120

FloPatch FP120 is an FDA 510(k) cleared device indicated for the non-invasive assessment of blood flow in the carotid artery by medical professionals, such as physicians and nurses. FloPatch uses ultrasound and the Doppler effect to assess blood flow.

Sponsors & Collaborators

  • Flosonics Medical

    collaborator UNKNOWN
  • Northwell Health

    lead OTHER

Principal Investigators

  • Allison Cohen, MD · North Shore University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-06
Primary Completion
2024-09-06
Completion
2024-09-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05558228 on ClinicalTrials.gov